📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

FAVOR III China: quantitative flow ratio-guided coronary intervention in practice. (2022)

First Author: Ang D

Attributed to: MICA: A Developmental Trial of Personalised Medicine for Repurposing Zibotentan, a Selective Endothelin A Receptor Blocker, in Microvascular Angina. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/cvr/cvac109

PubMed Identifier: 36000975

Publication URI: http://europepmc.org/abstract/MED/36000975

Type: Journal Article/Review

Volume: 118

Parent Publication: Cardiovascular research

Issue: 11

ISSN: 0008-6363